Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

NA Proactive news snapshot: GreenBank Capital, Cardiol Therapeutics, OTC Markets, Murchison Minerals, Marble Financial UPDATE ...

Stock Markets Aug 03, 2022 17:15
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
NA Proactive news snapshot: GreenBank Capital, Cardiol Therapeutics, OTC Markets, Murchison Minerals, Marble Financial UPDATE ...
 
Gold
-1.14%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Copper
-1.41%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BTC/EUR
+2.29%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BTC/USD
+2.96%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TGTB34
+4.80%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
KECR
-1.33%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

GreenBank Capital Inc, the next-generation investment firm, told investors it had bought another 29.5% of Staminier Ltd and acquired a loan made to Staminier worth almost £5 million. GreenBank's holding in Staminier is lifted to 48.5% after the latter's shareholders gave notice they wished to exercise a 2020 put option. GreenBank also noted that separately, on August 1, it had agreed to acquire a loan of £4.975 million (C$7.71M) made to Staminier plus interest accrued to date (C$822,400) and accruing in the future (C$51,700 per month). The loan carries a 100% premium (C$7,710,00) if not repaid or converted by March 2024.

Cardiol Therapeutics Inc. announced that the first patient has been enrolled in ARCHER, a Phase 2 trial designed to study the safety and tolerability of the oral cannabinoid formulation CardiolRx in patients with acute myocarditis. CardiolRx is a pharmaceutically produced formulation being developed for the treatment of acute and chronic inflammation associated with heart disease. The ARCHER study has received Investigational New Drug (IND) clearance from the Food and Drug Administration. The plan is to enroll 100 patients at major cardiac centers in North America, Europe, Latin America, and Israel.

OTC Markets Group Inc announced it will report its financial results for the second quarter ended June 30, 2022, after the close of the US capital markets on August 10, 2022. In addition, the company will host a conference call and webcast on August 11, 2022, at 8:30 am ET, during which management will discuss the financial results in further detail. The conference webcast and management presentation can be accessed here. Investors planning to ask a question during the live call and Q&A session should register here.

Murchison Minerals Ltd revealed that it approved the issuance of 4.70 million stock options to directors, officers, employees, and consultants of the company. The options are exercisable into common shares of the company at a price of $0.09 expiring on July 29, 2027. The options vested immediately. The Burlington, Ontario-based exploration company is focused on nickel-copper-cobalt exploration at its HPM project in Quebec and the exploration and development of its Brabant Lake zinc-copper-silver project in north-central Saskatchewan. The firm also holds an option to earn 100% interest in the Barraute VMS exploration project in Quebec.

Marble Financial Inc has said it completed 11 new license agreements in July, including 10 with its open banking proprietary software platform, Inverite Verification Inc, and one with its business-to-business-to-consumer (B2B2C) credit nurturing Marble Connect. Of these 11 licensees, seven have gone live on the Inverite open banking platform. The AI-driven financial technology company said its proprietary products are gaining recognition and acceptability in both the alternative lending and credit nurturing sectors focussing on the roughly 30% of Canadian consumers who are underbanked due to subprime credit scores.

BioLargo Inc said it has set a new quarterly revenue record thanks in part to expanded sales of pet control products and wastewater treatment technologies. The company generated around $1.3 million in revenue during the second quarter of 2022, a 37% increase from the first quarter of 2022, and a 185% increase from the second quarter of 2021.

Progressive Planet Solutions Inc has announced the finalization of its amended agreement with International Zeolite Corporation (IZ) to purchase a 50% interest in the Bromley Creek zeolite mine in Princeton, British Columbia. The Kamloops, British Columbia-based company, which provides circular solutions using micronized minerals for the cement and agricultural sectors, said the agreement creates a “systematic payment schedule over the next five years". The amended agreement outlines the payment details for the 50% interest for the sum of $725,000. According to the firm, $101,933.76 has already been paid to IZ, with PLAN now holding a 7.03% interest in the Bromley Creek zeolite mine.

Pathway Health Corp has announced the appointment of Dr Rakesh Jetly as an independent member of the company's board of directors. Jetly will also join the compensation and governance committee as chair following the resignation of Pathway Health director Michael Steele. “We are excited to welcome Dr Jetly to our board of directors and look forward to leveraging his expertise and insights in mental health as we continue to expand the services offered to our patients,” Pathway Health CEO Ken Yoon said in a statement.

Braxia Scientific Corp said it has acquired KetaMD Inc, a US-based telemedicine company focused on addressing mental health challenges through access to technology-facilitated ketamine-based treatments. "Today marks a notable step forward in bringing awareness, accessibility and scalability of the benefits of ketamine and psychedelics generally for those suffering from depression and other mood disorders," Braxia Scientific CEO Dr Roger McIntyre said in a statement. "We've seen improved outcomes first-hand from ketamine treatment in our clinics and in our clinical trials. Adding digital telehealth capabilities through KetaMD's highly-anticipated online and mobile platform strengthens our position to lead the medical use of evidence-based psychedelics, while accelerating our ability to get treatment to those in need, safely and quickly across the US and Canada, and globally in the future. I'm delighted the KetaMD leadership will be bringing their immeasurable talents as key leaders in the organization and as Braxia shareholders," he added.

Cloud DX Inc said it has signed a new contract with a primary care clinic in Michigan, in a deal that further expands its US operations. The digital health platform said the Michigan clinic will use Cloud's Remote Patient Monitoring (RPM) solution, complete with its Connected Health kit, to improve outcomes for patients with chronic conditions. With active patient onboarding in nine states, this Michigan contract further deepens Cloud DX's US roots, the company said. Cloud's US clinical customers are implementing RPM solutions in Georgia, Illinois, Indiana, Massachusetts, Michigan, New Jersey, Oregon, Pennsylvania, and Tennessee.

American Manganese Inc has said it is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a feasibility study targeting the removal of fluoride from black mass containing high concentrations of the mineral. At the end of their life, lithium-ion batteries undergo a mechanical pre-treatment method that produces a black mass material containing lithium, nickel, manganese, cobalt, and impurities such as fluoride. These impurities can cause significant corrosion and contamination issues in the downstream hydrometallurgical processing steps. The company said it has identified some black mass containing a high concentration of fluoride. "Innovation is at our core, and our goal is to stay ahead of the curve and offer the most advanced lithium-ion battery recycling and upcycling technology. We are thankful to NRC IRAP for its advisory services and funding support that enables our company to optimize our technology further," Larry Reaugh, president and CEO of American Manganese, said in a statement

FansUnite Entertainment Inc said its sports betting company Betting Hero has entered into an agreement with Bankroll, a new luxury sports bar experience coming in the fall to Philadelphia, Pennsylvania. The global sports and entertainment company said Betting Hero will help build Bankroll’s sports betting-focused concierge team, focusing on VIP customer engagement, customer acquisition, and building relationships with gambling and sports betting companies. “This latest venture with Bankroll is another illustration of why Betting Hero is expanding so rapidly and why their unique offerings have made them the top live activation company in the country,” FansUnite CEO Scott Burton said in a statement.

Endeavour Mining PLC, a West Africa-focused gold producer, hiked its interim dividend by 43% to 40 US cents per share thanks to its improved financial position and confident outlook. It plans to pay US$100mln in interim dividends and said it is now targeting a minimum dividend of US$200mln for the year, US$50mln more than its initial minimum commitment, the company said in its interim results. It produced 702,000 ounces of gold at an all-in sustaining cost (AISC) of US$900 an ounce and reiterated its full-year output guidance of 1.32mln to 1.40mln ounces at an AISC of US$880-930 an ounce.

Gevo Inc said it has entered into a new fuel sales agreement with Alaska Airlines to purchase 37 million gallons of sustainable aviation fuel (SAF) per year over a five-year period. The company said its SAF deliveries were expected to begin in 2026. Gevo noted that Alaska Airlines was a member of the Oneworld alliance and that this agreement fell under the purview of a memorandum of understanding signed in March 2022, laying the groundwork for the 14 airlines in the alliance to potentially purchase 200 million gallons per year of SAF from Gevo’s future commercial production operations.

Lingo Media Corporation said its Everybody Loves Languages (ELL) subsidiary has announced an additional sale in Colombia by securing another contract with language training and test-prep education provider Sophia Educational Group. The edtech language-learning and content development company noted the ELL language-learning system will be offered to students from preschool to grade 11. “We continue to expand our reach in Latin America through relationships with new customers like Sophia Educational Group,” Lingo Media and ELL CEO Gali Bar-Ziv said in a statement.

Imagine AR Inc. has announced the launch of soccer legend Ronaldinho's new augmented reality (AR) experience. The R10 Lens, developed by Jet Media Network and powered by the technology of ImagineAR, allows Ronaldinho's fans to access AR filters via the Brazilian star's official app and create shareable videos with their hero. Ronaldo de Assis Moreira is a retired professional footballer who won two FIFA World Player of the Year awards while playing for Barcelona, before moving to AC Milan and then returning to play for Brazilian teams. In 2004, Pele named Ronaldinho one of FIFA’s top 100 living players.

AMPD Ventures Inc announced that its subsidiary Departure Lounge’s Metastage Volumetric Capture Stage has received its certification to operate from Microsoft (NASDAQ:MSFT) Mixed Reality Capture Studios. One of the highest resolution volumetric video capture stages in the world, the 6,000-square foot stage is now open for business, the company said. The stage features 106 12-megapixel machine-vision cameras to capture dynamic, ultra-high fidelity human performances using Microsoft’s capture technology and its Azure rendering pipeline. The three-dimensional holograms that are created can be placed into fully digital and blended reality locations, narratives, games, and experiences. “The Departure Lounge and Metastage teams have been working exceptionally hard over the last year to build and test the stage here in Vancouver,” Adam Rogers, VP Creative and Head of Studio at Departure Lounge said in a statement.

Metal Energy Corp has said results from its first phase drill program at its nickel and copper-cobalt Manibridge project in Manitoba, were better than expected and highlighted the asset's potential. James Sykes, CEO of Metal Energy, said in a statement: "We're excited to continue exploring and developing Manibridge with our Phase Two and future drill programs." Assay highlights included 0.92% nickel-equivalent (Ni-Eq) over a length of 32.95 metres (m) starting at 150.45m depth, including 1.24% Ni Eq over 11.45m at 169.1m in one hole. Another hole intersected 1.13% Ni Eq over 9m, starting at 700m depth, including 1.62% Ni Eq over 5m at 701 m depth in another.

Nextech AR Solutions Corp said it has launched a new technology advancement with AR Wayfinding as well as upgrades to its augmented reality spatial mapping platform, ARway. ARway and Map D, a self-serve event management software solution, are now offering clients a total package event management product that now includes AR wayfinding, opening up another potential revenue driver, the company said. AR Wayfinding is well suited for expos, trade shows, conferences, and festivals. It adds big value to event management software by providing wayfinding meta maps, engaging spatial experiences, and deep location intelligence. ARway is now well positioned to be making groundbreaking new experiences—with no programming required, Nextech noted.

Todos Medical Ltd has said it is set to branch into the world of MonkeyPox testing through its subsidiary Provista Diagnostics Inc, which has started a validation plan for PCR-based testing. Todos acquired the US-based medical diagnostics company Provista to gain rights to its Alpharetta, Georgia-based CLIA/CAP-certified lab, which is currently performing PCR COVID testing, Long COVID Panel, and Provista's proprietary commercial-stage Videssa breast cancer blood test. "The significant investment we made to automate PCR testing at Provista to maximize COVID testing capacity can now be partially redeployed towards MonkeyPox as we prepare to help the nation scale-up MonkeyPox testing capacity to meet the emerging public health crisis," said Gerald E. Commissiong, the CEO of Todos Medical, in a statement.

Golden Minerals Company has reported assay results from the first 10 holes of a 22-hole, second phase diamond drill (DD) program recently completed at its Sarita Este property in Salta Province, Argentina. The company said it has drilled 22 DD holes totaling 1,286 metres (m), focusing on exploration drilling following up on the Sico epithermal target drilled in 2021 as part of an option agreement with Cascadero Copper Corp. (CCD). "Initial results for the second drill campaign at the Sico epithermal deposit continue to show strong potential for a shallow economic oxide gold deposit. Assays are pending on the results from drilling to the west of the discovery hole and we are planning a follow-up drill campaign to start in mid-August to continue delineating the deposit," said Warren Rehn, president and chief executive officer of Golden Minerals in a statement.

PlantX Life Inc has announced the international expansion of its Little West cold-pressed juice brand and e-commerce platform into Canada. As part of the expansion, Little West has launched a Canadian version of its e-commerce website, at littlewestjuice.ca, and plans to expand its wholesale business into physical retail outlets across the country. Acquired by PlantX in May 2021, Little West is a California-based cold-pressed juice company that offers a range of beverages and products that emphasize health and wellness with a focus on local sources, made with high quality and fresh ingredients.

Snowline Gold Corp has told investors it is "very encouraged" by the scale of the system at its Rogue project in the Yukon, where the company said it has found gold-bearing quartz vein mineralization. Sheeted vein mineralization has been observed across a 700-metre (m) by 800m area at the Valley zone at the property, with mineralization open in all directions with wider step-out holes planned. "We are very encouraged by the scale of the mineralized system we are seeing at Valley," Snowline CEO Scott Berdahl said in a statement. "Each successful step-out across hundreds of metres adds significantly to the bulk-tonnage potential of the target, and mineralization is present from surface to the bottoms of the deepest holes we've drilled to date to 554m downhole corresponding to 430m below surface. Of course, we won't know the true significance of the discovery until we have drill core assays back. Lab estimates now point to mid-August for return of our first holes of the 2022 exploration season," he added.

DGTL Holdings Inc revealed that its wholly-owned subsidiary Engagement Labs has secured four new Platform-as-a-Service (PaaS) contracts from two global consumer packaged goods (CPG) conglomerates. The New-York based group, which is building a portfolio of digital media software subsidiaries, noted that an NYSE-listed CPG global conglomerate is now a new client under DGTL management. The combined deals are valued at over $180,000 and are focused on measuring the effectiveness of digital advertising and sports marketing sponsorships activated during "the top broadcasted sporting event in North America", said the company.

New Age Metals Inc has issued an update on exploration at its lithium projects in Manitoba, Canada, saying that a maiden 1,000 metre (m) diamond drill program at the historic Silverleaf target on the Lithium One project was slated to begin at the end of August this year. New Age is partnered with Mineral Resource Ltd, the world's fourth largest lithium producer, at the projects and is funding the exploration. This year's budget is C$1.8 million. The company's lithium properties sit within the Winnipeg river pegmatite field which hosts the world-class Tanco pegmatite that has been mined for tantalum, cesium and lithium in varying capacities, since 1969.

Fabled Copper Corp has updated on the 2022 field exploration programs on its Muskwa Copper Project which comprises the Neil Property, the Toro Property and the Bronson Property in northern British Columbia. "Louis Martin our senior technical Board member and myself just returned from a site visit on the Muskwa Project and are pleased to say things are progressing nicely. This year's program was started one month earlier than last year and much more focused,” Peter Hawley, president of Fabled Copper, said in a statement. In March 2022, the company applied for a 15-drill-pad, three-holes-per-pad good for 5-year drill permit to relevant Department of Mines, Permitting. In July, bonding was requested and was posted. At present, the Inspector of Mines, Permitting and the relevant First Nations are in consultation.

VolitionRx Limited revealed that it has been awarded a further $1.5 million in non-dilutive funding from Namur Invest Capital Risk in Belgium. The Austin, Texas-based epigenetics company said Namur Invest's award will fund an early access program for Volition's Nu.Q product portfolio at key sites across the EU, UK, and the United States. In a statement, Volition COO Gaetan Michel said: "Thanks to this latest funding from Namur Invest, we are incredibly excited to launch our early access program and engage industry leaders in the development and adoption of our transformative Nucleosomics technology in a range of exemplifications of our assays.”

PharmaDrug Inc said it is one step closer to streamlining its focus into a pure-play biotech company with the closing of the sale of its cannabis assets. The company said it has closed the previously announced sale of all of the issued and outstanding securities of Pharmadrug Production GmbH, a German medical cannabis distributor, to Khiron Life Sciences Corp. Pursuant to the terms of the transaction, Khiron issued to Pharmadrug 5,500,000 shares of the company at a deemed price of $0.16 per share and an additional 468,750 shares in connection with certain closing adjustments for a total of 5,968,750 common shares.

CleanSpark Inc has released its unaudited bitcoin (BTC) mining and operations update for the calendar year-to-date ending July 31, 2022, showing that it mined 384 bitcoin in July, taking the calendar year-to-date total to 2,247 bitcoin mined. The company said its total BTC holdings as of July 31 were 519, and total BTC converted for operations and growth in July were 426. CleanSpark has a currently deployed fleet of approximately 30,450 latest-generation bitcoin miners with a total hashrate of 2.9 EH/s. The company said it fully funded growth and operations through the sale of 426 bitcoins in July 2022 at an average of approximately $20,768 per BTC., and sales of BTC equated to proceeds of approximately $8.8 million. CleanSpark noted that July daily BTC mined reached a high of 13.25.

Algernon Pharmaceuticals Inc said it has been invited to present the results from its phase 2a study of NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough at the 9th American Cough Conference in June 2023. The American Cough Conference is the world's leading educational meeting for health care professionals involved in the research and management of patients with cough and is held every two years. Ifenprodil is an N-methyl-D-aspartate (NMDA) receptor antagonist specifically targeting the NMDA-type subunit 2B (GluN2B), which prevents glutamate signalling. Ifenprodil represents a novel first-in-class treatment for both IPF and chronic cough. "I am pleased that Algernon has accepted our invitation to present at the American Cough Conference," said Dr Peter Dicpinigaitis, professor of Medicine at Albert Einstein College of Medicine, editor-in-chief of LUNG, and conference chair.

MedX Health Corp has announced the appointment of Tarek El Hoss as vice president for market development and sales to oversee global initiatives to drive immediate revenue generation and growth. El Hoss has over 20 years of demonstrated success in the medical technology industry, including as business director for Medtronic (NYSE:MDT) in the Middle East, Africa, Central Asia and Turkey, where he was responsible for driving sales, establishing distribution channels and new product launches, the Ontario-based company noted. "Over the past year, we've announced commercial partnerships to make our DermSecure skin screening technology available to serve patients throughout Europe, the Middle East and Canada," MedX president and CEO Naman Demaghlatrous said in a statement.

American Battery Technology Company (ABTC) has announced the appointment of Lane Belanger as the company’s staff analytical chemist. The critical battery materials company said the appointment is part of its continued acquisition of highly-competitive battery materials technical talent as well as the expansion of its research and development division that focuses on battery metals extraction and qualification processes. It said Belanger previously worked for more than four years at Tesla (NASDAQ:TSLA) within the Gigalab quality laboratory at its Reno Gigafactory, where he was actively involved in developing several analytical methods for a variety of lithium-bearing and other battery materials using GC-MS and ICP-OES instruments.

Doubleview Gold Corp said it has received final TSX approval for its non-brokered flow-through and non-flow-through private placement of total gross proceeds of $3,068,241.20, with $969,991.20 raised from flow-through (FT) units and $2,098,250 from non-flow-through (NFT) units. The aggregate gross proceeds of the FT units will be used for contribution and maintenance of the company's exploration work on its projects, particularly for the Hat Project. The aggregate gross proceeds of the NFT units will be used for the company's exploration work on its projects, particularly for the Hat Project and for general administrative costs. In the third tranche of the financing, Doubleview issued a total of 1,370,000 FT units at a price of $0.30 each for total gross proceeds of $411,000. The company also issued 520,000 NFT units in the third tranche at a price of $0.25 each for total proceeds of $130,000.

Newrange Gold Corp said it has arranged a non-brokered private placement of up to 10 million units at three cents per unit to raise gross proceeds of up to $300,000. Each Unit shall consist of one common share in the capital of the Company and one share purchase warrant, with each warrant convertible into an additional share at an exercise price of $0.05 for a period of 24 months from the date of issuance. The net proceeds raised from the offering will be used for general working capital, including final due diligence on a potential acquisition. All securities to be issued will be subject to a four-month hold period from the date of issuance and subject to TSX Venture Exchange approval. The securities offered have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

The Valens Company Inc has announced the voting results from its Annual General Meeting of shareholders held by way of live audio webcast on August 2, 2022. Six of the director nominees that were put forward by the company were elected by shareholders at the meeting to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. KPMG LLP was also reappointed by shareholders at the meeting. Although extensively vetted by the Nominating and Governance Committee of the company and initially confirming her ability and interest to stand as a director nominee for election at the meeting, immediately prior to the commencement of the meeting, Aida Moudachirou-Rebois advised the company that due to unanticipated circumstances unrelated to the company, she is precluded from serving and accordingly had to withdraw her consent. She was, therefore, not eligible to stand for election to the board of directors.

Naturally Splendid Enterprises Ltd has said it intends to consolidate its issued and outstanding common shares at a ratio of up to 15 pre-consolidation shares to 1 post-consolidation share. The purpose of the consolidation is to facilitate the company's ability to attract future financings, generate greater investor interest, and improve trading liquidity. The company currently has 330,624,458 common shares issued and outstanding. In the event the company proceeds with the consolidation, as opposed to a lesser ratio, the company anticipates there would be 22,041,631 common shares issued and outstanding. The consolidation is subject to acceptance from the TSX-V and approval of the shareholders. The company has scheduled the holding of an Annual General and Special Meeting for August 30, 2022.

BioVaxys Technology Corp said that further to its news release dated July 4, 2022, it has settled an aggregate of $517,854 in debt through the issuance of common shares issued at a deemed price of $0.10 per common share.

Cordoba Minerals Corp said its board of directors have approved the award of an aggregate of 2,870,800 in stock options, long-term incentive grants (RSUs) and deferred share units (DSUs) to its directors, officers, consultants and employees to acquire up to an aggregate of 2,870,800 common shares in the capital of the company. 1,167,050 stock options were granted to directors, officers, consultants and employees exercisable at a price of $0.53 per common share and vesting one-third six months after the date of the grant, with an additional third vesting 12 months after the date of grant and the remaining third vesting two years after the date of grant. Those granted to investor relations employees will vest as to one-third after 12 months and two-thirds after 24 months. The options expire on August 1, 2027. In addition, 1,328,750 RSUs were granted to officers, consultants and employees, which will vest as to one-third on each of the first, second and third anniversaries of the date of the grant, and 375,000 DSUs were granted, which are solely awarded to the directors, and will be redeemable upon the retirement or replacement of a director.

Cabral Gold Inc said the TSX Venture Exchange has accepted for filing documentation with respect to its brokered private placement announced on June 8, 2022, which will see the issue of 10,138,358 shares at a purchase price of 30 cents per share, together with 10,138,358 share purchase warrants with an exercise price of 50 cents for a two-year period with 31 placees.

East Side Games Group Inc has said it will release its second quarter 2022 financial results on Thursday, August 11, 2022, after the market close. Following the release, the company will hold a webcast and conference call to discuss its performance with the investment community at 2.00pm PT on the same day. Webcast URL: https://app.webinar.net/Ep90bBxR5NB. Conference Call Details: Toll-Free Dial-In Number +1 (888) 440-2009; International Dial-In Number +1 (438) 803-0546; conference ID: 8631585 A replay will be available starting at 6.30am PT August 12, 2022 until September 11, 2022, by dialing +1 (800) 770-2030 or +1 (647) 362-9199 and entering the conference ID 8631585.

Recruiter.com Group Inc has said it will host a conference call and audio webcast on Monday, August 15, 2022, to discuss its financial results for the second quarter ended June 30, 2022. The company plans to release its second-quarter financial results press release at approximately 4.00pm EDT. 1.30pm PDT, on Monday, August 15, 2022. Recruiter.com's chairman and CEO Evan Sohn, CFO Judy Krandel, and president and COO Miles Jennings will provide an operational and financial summary of the second quarter results on a video call, with a live question and answer session, on Monday, August 15th, at 4:30 p.m. EDT /. Or to register for the live webcast and view the presentation, interested parties can use the following link: https://www.webcaster4.com/Webcast/Page/2765/46178. To access the conference by phone: US Dial-in: 877-545-0320; International Dial-in: 877-545-0320; passcode 413648. The webcast will be available on investors.recruiter.com for at least 90 days.

Xeris Biopharma Holdings Inc has announced that the company will release its second quarter 2022 financial results before the open of the US financial markets on Wednesday, August 10, 2022. Management will host a conference call and webcast at 8.30am Eastern Time that day to discuss the financial and operational results. Interested parties can pre-register for the conference call via the following ink: https://ige.netroadshow.com/registration/q4inc/11152/xeris-biopharma-second-quarter-2022-financial-results-call/. Following the conference call, a replay will be available until Wednesday, August 24, 2022, via: US 1 929 458 6194, US Toll-Free 1 866 813 9403, UK 0204 525 0658, Canada:1 226 828 7578, or all other locations +44 204 525 0658; access code 562978. In addition, a live audio of the conference call will be available as a webcast. To join the webcast, interested parties can visit 'Events' on investor relations page of the company's website at www.xerispharma.com.

VolitionRx Limited has said that company executives Cameron Reynolds, CEO, and Scott Powell, head of Investor Relations, will be attending the Q3 Virtual Investor Summit being held on August 16 & 17, 2022. During a presentation on August 16, 2022, at 2.00pm ET, Reynolds will highlight the company's transformational business strategy, disruptive technology, noteworthy collaborations and partnerships, and the broader going-forward corporate vision. The presentation will be webcast via the following link: https://us06web.zoom.us/webinar/register/WN_rj6IiMFtTemrMQGEyz5L6wReynolds. An archived recording will be made available in the Investors' section of the VolitionRx Limited website. The conference is completely complementary to qualified investors and 1x1s will be available for qualified investors who can register at https://www.meetmax.com/sched/event_85009/investor_reg_new.html?attendee_role_id=ISG_INVESTOR

Vyant Bio Inc has announced that it will be participating in the Q3 Virtual Investor Summit being held on August 16 & 17, 2022. During a presentation on August 16, 2022, at 2.00pm ET, Vyant Bio's chief executive officer, Jay Roberts, will be discussing key milestones and achievements on the scientific, business, and strategic fronts. The presentation will be webcast via the following link: https://us06web.zoom.us/webinar/register/WN_rj6IiMFtTemrMQGEyz5L6w. The presentation slides will also be available in the Investors' section of the Vyant Bio website. The conference is completely complementary to qualified investors and 1x1s will be available for qualified investors who can register at https://www.meetmax.com/sched/event_85009/investor_reg_new.html?attendee_role_id=ISG_INVESTOR

Zynerba Pharmaceuticals Inc has announced that Armando Anido, its chairman and chief executive officer will present an overview and update of the company at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022, at 9.00am ET at the InterContinental Boston in Boston, Massachusetts. Investors interested in arranging an in-person meeting with the Company's management during the conference should contact the Canaccord Genuity conference coordinator. An archived webcast of the presentation will be available on-demand for 60 days following the event under the Events & webcasts tab of the Investors section of the Zynerba website at www.zynerba.com.

Read more on Proactive Investors CA

Disclaimer

NA Proactive news snapshot: GreenBank Capital, Cardiol Therapeutics, OTC Markets, Murchison Minerals, Marble Financial UPDATE ...
 

Related Articles

Porsche AG Shares Debut on Frankfurt Boerse
Porsche AG Shares Debut on Frankfurt Boerse By Investing.com - Sep 29, 2022

By Scott Kanowsky  Investing.com -- Shares in Dr. Ing. h.c. F. Porsche AG Preferred (F:P911_p) debuted on the Frankfurt Stock Exchange on Thursday, as owner Volkswagen (ETR:VOWG)...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email